HEMATOLOGY-ONCOLOGY ASSOCIATES OF CENTRAL NEW YORK, P.C. has sponsored the creation of one or more 401k plans.
Additional information about HEMATOLOGY-ONCOLOGY ASSOCIATES OF CENTRAL NEW YORK, P.C.
Submission information for form 5500 for 401k plan HEMATOLOGY-ONCOLOGY ASSOCIATES OF CENTRAL NEW YORK P.C. 401(K) PROFIT SHARING PLAN
401k plan membership statisitcs for HEMATOLOGY-ONCOLOGY ASSOCIATES OF CENTRAL NEW YORK P.C. 401(K) PROFIT SHARING PLAN
Measure | Date | Value |
---|
2022 : HEMATOLOGY-ONCOLOGY ASSOCIATES OF CENTRAL NEW YORK P.C. 401(K) PROFIT SHARING PLAN 2022 401k financial data |
---|
Total unrealized appreciation/depreciation of assets | 2022-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-12-31 | $0 |
Total income from all sources (including contributions) | 2022-12-31 | $-2,892,842 |
Total loss/gain on sale of assets | 2022-12-31 | $0 |
Total of all expenses incurred | 2022-12-31 | $2,651,037 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2022-12-31 | $2,615,436 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2022-12-31 | $4,303,026 |
Value of total assets at end of year | 2022-12-31 | $54,384,392 |
Value of total assets at beginning of year | 2022-12-31 | $59,928,271 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2022-12-31 | $35,601 |
Total interest from all sources | 2022-12-31 | $35,997 |
Total dividends received (eg from common stock, registered investment company shares) | 2022-12-31 | $628,733 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2022-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2022-12-31 | $628,733 |
Was this plan covered by a fidelity bond | 2022-12-31 | Yes |
Value of fidelity bond cover | 2022-12-31 | $500,000 |
If this is an individual account plan, was there a blackout period | 2022-12-31 | No |
Were there any nonexempt tranactions with any party-in-interest | 2022-12-31 | No |
Contributions received from participants | 2022-12-31 | $2,070,271 |
Participant contributions at end of year | 2022-12-31 | $258,167 |
Participant contributions at beginning of year | 2022-12-31 | $241,849 |
Assets. Other investments not covered elsewhere at end of year | 2022-12-31 | $20,725,540 |
Assets. Other investments not covered elsewhere at beginning of year | 2022-12-31 | $21,603,119 |
Income. Received or receivable in cash from other sources (including rollovers) | 2022-12-31 | $501,782 |
Other income not declared elsewhere | 2022-12-31 | $-1,475,553 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-12-31 | No |
Value of net income/loss | 2022-12-31 | $-5,543,879 |
Value of net assets at end of year (total assets less liabilities) | 2022-12-31 | $54,384,392 |
Value of net assets at beginning of year (total assets less liabilities) | 2022-12-31 | $59,928,271 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2022-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2022-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2022-12-31 | No |
Investment advisory and management fees | 2022-12-31 | $26,965 |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2022-12-31 | $30,275,000 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2022-12-31 | $35,047,561 |
Interest on participant loans | 2022-12-31 | $12,279 |
Income. Interest from loans (other than to participants) | 2022-12-31 | $0 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2022-12-31 | $1,392,219 |
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2022-12-31 | $1,466,236 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2022-12-31 | $1,466,236 |
Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2022-12-31 | $23,718 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2022-12-31 | $-6,385,045 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2022-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2022-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2022-12-31 | No |
Contributions received in cash from employer | 2022-12-31 | $1,730,973 |
Employer contributions (assets) at end of year | 2022-12-31 | $1,733,466 |
Employer contributions (assets) at beginning of year | 2022-12-31 | $1,569,506 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2022-12-31 | $2,615,436 |
Contract administrator fees | 2022-12-31 | $8,636 |
Did the plan have assets held for investment | 2022-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2022-12-31 | No |
Opinion of an independent qualified public accountant for this plan | 2022-12-31 | Unqualified |
Accountancy firm name | 2022-12-31 | BONADIO & CO., LLP |
Accountancy firm EIN | 2022-12-31 | 161131146 |
2021 : HEMATOLOGY-ONCOLOGY ASSOCIATES OF CENTRAL NEW YORK P.C. 401(K) PROFIT SHARING PLAN 2021 401k financial data |
---|
Total unrealized appreciation/depreciation of assets | 2021-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2021-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2021-12-31 | $35,389 |
Total income from all sources (including contributions) | 2021-12-31 | $12,242,775 |
Total loss/gain on sale of assets | 2021-12-31 | $0 |
Total of all expenses incurred | 2021-12-31 | $3,593,507 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2021-12-31 | $3,573,497 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2021-12-31 | $5,232,276 |
Value of total assets at end of year | 2021-12-31 | $59,928,271 |
Value of total assets at beginning of year | 2021-12-31 | $51,314,392 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2021-12-31 | $20,010 |
Total interest from all sources | 2021-12-31 | $12,338 |
Total dividends received (eg from common stock, registered investment company shares) | 2021-12-31 | $556,558 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2021-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2021-12-31 | $556,558 |
Was this plan covered by a fidelity bond | 2021-12-31 | Yes |
Value of fidelity bond cover | 2021-12-31 | $500,000 |
If this is an individual account plan, was there a blackout period | 2021-12-31 | No |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2021-12-31 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2021-12-31 | No |
Contributions received from participants | 2021-12-31 | $1,940,071 |
Participant contributions at end of year | 2021-12-31 | $241,849 |
Participant contributions at beginning of year | 2021-12-31 | $258,622 |
Assets. Other investments not covered elsewhere at end of year | 2021-12-31 | $21,603,119 |
Assets. Other investments not covered elsewhere at beginning of year | 2021-12-31 | $16,826,615 |
Income. Received or receivable in cash from other sources (including rollovers) | 2021-12-31 | $1,717,522 |
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2021-12-31 | $35,389 |
Other income not declared elsewhere | 2021-12-31 | $0 |
Administrative expenses (other) incurred | 2021-12-31 | $6,535 |
Total non interest bearing cash at end of year | 2021-12-31 | $0 |
Total non interest bearing cash at beginning of year | 2021-12-31 | $2,400 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2021-12-31 | No |
Value of net income/loss | 2021-12-31 | $8,649,268 |
Value of net assets at end of year (total assets less liabilities) | 2021-12-31 | $59,928,271 |
Value of net assets at beginning of year (total assets less liabilities) | 2021-12-31 | $51,279,003 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2021-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2021-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2021-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2021-12-31 | $35,047,561 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2021-12-31 | $31,158,469 |
Interest on participant loans | 2021-12-31 | $11,435 |
Income. Interest from loans (other than to participants) | 2021-12-31 | $0 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2021-12-31 | $1,466,236 |
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2021-12-31 | $1,594,281 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2021-12-31 | $1,594,281 |
Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2021-12-31 | $903 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2021-12-31 | $6,441,603 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2021-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2021-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2021-12-31 | No |
Contributions received in cash from employer | 2021-12-31 | $1,574,683 |
Employer contributions (assets) at end of year | 2021-12-31 | $1,569,506 |
Employer contributions (assets) at beginning of year | 2021-12-31 | $1,474,005 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2021-12-31 | $3,573,497 |
Contract administrator fees | 2021-12-31 | $13,475 |
Did the plan have assets held for investment | 2021-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2021-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2021-12-31 | No |
Opinion of an independent qualified public accountant for this plan | 2021-12-31 | Unqualified |
Accountancy firm name | 2021-12-31 | BONADIO & CO., LLP |
Accountancy firm EIN | 2021-12-31 | 161131146 |
2020 : HEMATOLOGY-ONCOLOGY ASSOCIATES OF CENTRAL NEW YORK P.C. 401(K) PROFIT SHARING PLAN 2020 401k financial data |
---|
Total unrealized appreciation/depreciation of assets | 2020-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2020-12-31 | $35,389 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2020-12-31 | $12,500 |
Total income from all sources (including contributions) | 2020-12-31 | $8,735,615 |
Total loss/gain on sale of assets | 2020-12-31 | $0 |
Total of all expenses incurred | 2020-12-31 | $4,117,415 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2020-12-31 | $4,076,511 |
Value of total corrective distributions | 2020-12-31 | $36,094 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2020-12-31 | $3,469,902 |
Value of total assets at end of year | 2020-12-31 | $51,314,392 |
Value of total assets at beginning of year | 2020-12-31 | $46,673,303 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2020-12-31 | $4,810 |
Total interest from all sources | 2020-12-31 | $13,488 |
Total dividends received (eg from common stock, registered investment company shares) | 2020-12-31 | $1,429,028 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2020-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2020-12-31 | $1,429,028 |
Was this plan covered by a fidelity bond | 2020-12-31 | Yes |
Value of fidelity bond cover | 2020-12-31 | $500,000 |
If this is an individual account plan, was there a blackout period | 2020-12-31 | Yes |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2020-12-31 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2020-12-31 | No |
Contributions received from participants | 2020-12-31 | $1,758,578 |
Participant contributions at end of year | 2020-12-31 | $258,622 |
Participant contributions at beginning of year | 2020-12-31 | $291,083 |
Assets. Other investments not covered elsewhere at end of year | 2020-12-31 | $16,826,615 |
Assets. Other investments not covered elsewhere at beginning of year | 2020-12-31 | $15,254,339 |
Income. Received or receivable in cash from other sources (including rollovers) | 2020-12-31 | $237,319 |
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2020-12-31 | $35,389 |
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2020-12-31 | $12,500 |
Other income not declared elsewhere | 2020-12-31 | $0 |
Total non interest bearing cash at end of year | 2020-12-31 | $2,400 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2020-12-31 | No |
Value of net income/loss | 2020-12-31 | $4,618,200 |
Value of net assets at end of year (total assets less liabilities) | 2020-12-31 | $51,279,003 |
Value of net assets at beginning of year (total assets less liabilities) | 2020-12-31 | $46,660,803 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2020-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2020-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2020-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2020-12-31 | $31,158,469 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2020-12-31 | $28,077,567 |
Interest on participant loans | 2020-12-31 | $13,488 |
Income. Interest from loans (other than to participants) | 2020-12-31 | $0 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2020-12-31 | $1,594,281 |
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2020-12-31 | $1,607,193 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2020-12-31 | $1,607,193 |
Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2020-12-31 | $0 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2020-12-31 | $3,823,197 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2020-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2020-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2020-12-31 | No |
Contributions received in cash from employer | 2020-12-31 | $1,474,005 |
Employer contributions (assets) at end of year | 2020-12-31 | $1,474,005 |
Employer contributions (assets) at beginning of year | 2020-12-31 | $1,443,121 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2020-12-31 | $4,076,511 |
Contract administrator fees | 2020-12-31 | $4,810 |
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2020-12-31 | Yes |
Did the plan have assets held for investment | 2020-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2020-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2020-12-31 | No |
Opinion of an independent qualified public accountant for this plan | 2020-12-31 | Disclaimer |
Accountancy firm name | 2020-12-31 | BONADIO & CO., LLP |
Accountancy firm EIN | 2020-12-31 | 161131146 |
2019 : HEMATOLOGY-ONCOLOGY ASSOCIATES OF CENTRAL NEW YORK P.C. 401(K) PROFIT SHARING PLAN 2019 401k financial data |
---|
Total unrealized appreciation/depreciation of assets | 2019-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2019-12-31 | $12,500 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2019-12-31 | $38,821 |
Total income from all sources (including contributions) | 2019-12-31 | $10,458,117 |
Total loss/gain on sale of assets | 2019-12-31 | $0 |
Total of all expenses incurred | 2019-12-31 | $1,914,162 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2019-12-31 | $1,894,714 |
Value of total corrective distributions | 2019-12-31 | $12,500 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2019-12-31 | $3,086,018 |
Value of total assets at end of year | 2019-12-31 | $46,673,303 |
Value of total assets at beginning of year | 2019-12-31 | $38,155,669 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2019-12-31 | $6,948 |
Total interest from all sources | 2019-12-31 | $46,652 |
Total dividends received (eg from common stock, registered investment company shares) | 2019-12-31 | $732,102 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2019-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2019-12-31 | $732,102 |
Was this plan covered by a fidelity bond | 2019-12-31 | Yes |
Value of fidelity bond cover | 2019-12-31 | $500,000 |
If this is an individual account plan, was there a blackout period | 2019-12-31 | No |
Were there any nonexempt tranactions with any party-in-interest | 2019-12-31 | No |
Contributions received from participants | 2019-12-31 | $1,587,508 |
Participant contributions at end of year | 2019-12-31 | $291,083 |
Participant contributions at beginning of year | 2019-12-31 | $297,405 |
Assets. Other investments not covered elsewhere at end of year | 2019-12-31 | $15,254,339 |
Assets. Other investments not covered elsewhere at beginning of year | 2019-12-31 | $13,133,976 |
Income. Received or receivable in cash from other sources (including rollovers) | 2019-12-31 | $55,389 |
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2019-12-31 | $12,500 |
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2019-12-31 | $38,821 |
Other income not declared elsewhere | 2019-12-31 | $1,784,791 |
Administrative expenses (other) incurred | 2019-12-31 | $6,948 |
Total non interest bearing cash at end of year | 2019-12-31 | $0 |
Total non interest bearing cash at beginning of year | 2019-12-31 | $29,585 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2019-12-31 | No |
Value of net income/loss | 2019-12-31 | $8,543,955 |
Value of net assets at end of year (total assets less liabilities) | 2019-12-31 | $46,660,803 |
Value of net assets at beginning of year (total assets less liabilities) | 2019-12-31 | $38,116,848 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2019-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2019-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2019-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2019-12-31 | $28,077,567 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2019-12-31 | $21,737,702 |
Interest on participant loans | 2019-12-31 | $14,747 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2019-12-31 | $1,607,193 |
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2019-12-31 | $1,586,285 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2019-12-31 | $1,586,285 |
Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2019-12-31 | $31,905 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2019-12-31 | $4,808,554 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2019-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2019-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2019-12-31 | No |
Contributions received in cash from employer | 2019-12-31 | $1,443,121 |
Employer contributions (assets) at end of year | 2019-12-31 | $1,443,121 |
Employer contributions (assets) at beginning of year | 2019-12-31 | $1,370,716 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2019-12-31 | $1,894,714 |
Did the plan have assets held for investment | 2019-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2019-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2019-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2019-12-31 | Yes |
Opinion of an independent qualified public accountant for this plan | 2019-12-31 | Disclaimer |
Accountancy firm name | 2019-12-31 | BONADIO & CO., LLP |
Accountancy firm EIN | 2019-12-31 | 161131146 |
2018 : HEMATOLOGY-ONCOLOGY ASSOCIATES OF CENTRAL NEW YORK P.C. 401(K) PROFIT SHARING PLAN 2018 401k financial data |
---|
Total unrealized appreciation/depreciation of assets | 2018-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2018-12-31 | $38,821 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2018-12-31 | $0 |
Total income from all sources (including contributions) | 2018-12-31 | $1,398,529 |
Total loss/gain on sale of assets | 2018-12-31 | $0 |
Total of all expenses incurred | 2018-12-31 | $3,371,783 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2018-12-31 | $3,312,997 |
Value of total corrective distributions | 2018-12-31 | $52,109 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2018-12-31 | $3,263,817 |
Value of total assets at end of year | 2018-12-31 | $38,155,669 |
Value of total assets at beginning of year | 2018-12-31 | $40,090,102 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2018-12-31 | $6,677 |
Total interest from all sources | 2018-12-31 | $39,123 |
Total dividends received (eg from common stock, registered investment company shares) | 2018-12-31 | $1,042,385 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2018-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2018-12-31 | $1,042,385 |
Was this plan covered by a fidelity bond | 2018-12-31 | Yes |
Value of fidelity bond cover | 2018-12-31 | $600,000 |
If this is an individual account plan, was there a blackout period | 2018-12-31 | No |
Were there any nonexempt tranactions with any party-in-interest | 2018-12-31 | No |
Contributions received from participants | 2018-12-31 | $1,433,962 |
Participant contributions at end of year | 2018-12-31 | $297,405 |
Participant contributions at beginning of year | 2018-12-31 | $316,901 |
Assets. Other investments not covered elsewhere at end of year | 2018-12-31 | $13,133,976 |
Assets. Other investments not covered elsewhere at beginning of year | 2018-12-31 | $12,829,393 |
Income. Received or receivable in cash from other sources (including rollovers) | 2018-12-31 | $459,139 |
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2018-12-31 | $38,821 |
Other income not declared elsewhere | 2018-12-31 | $-579,077 |
Administrative expenses (other) incurred | 2018-12-31 | $6,677 |
Total non interest bearing cash at end of year | 2018-12-31 | $29,585 |
Total non interest bearing cash at beginning of year | 2018-12-31 | $183 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2018-12-31 | No |
Value of net income/loss | 2018-12-31 | $-1,973,254 |
Value of net assets at end of year (total assets less liabilities) | 2018-12-31 | $38,116,848 |
Value of net assets at beginning of year (total assets less liabilities) | 2018-12-31 | $40,090,102 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2018-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2018-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2018-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2018-12-31 | $21,737,702 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2018-12-31 | $24,116,185 |
Interest on participant loans | 2018-12-31 | $12,338 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2018-12-31 | $1,586,285 |
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2018-12-31 | $1,486,868 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2018-12-31 | $1,486,868 |
Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2018-12-31 | $26,785 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2018-12-31 | $-2,367,719 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2018-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2018-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2018-12-31 | No |
Contributions received in cash from employer | 2018-12-31 | $1,370,716 |
Employer contributions (assets) at end of year | 2018-12-31 | $1,370,716 |
Employer contributions (assets) at beginning of year | 2018-12-31 | $1,340,572 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2018-12-31 | $3,312,997 |
Did the plan have assets held for investment | 2018-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2018-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2018-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2018-12-31 | Yes |
Opinion of an independent qualified public accountant for this plan | 2018-12-31 | Disclaimer |
Accountancy firm name | 2018-12-31 | BONADIO & CO., LLP |
Accountancy firm EIN | 2018-12-31 | 161131146 |
2017 : HEMATOLOGY-ONCOLOGY ASSOCIATES OF CENTRAL NEW YORK P.C. 401(K) PROFIT SHARING PLAN 2017 401k financial data |
---|
Total unrealized appreciation/depreciation of assets | 2017-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2017-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2017-12-31 | $0 |
Total income from all sources (including contributions) | 2017-12-31 | $7,921,060 |
Total loss/gain on sale of assets | 2017-12-31 | $0 |
Total of all expenses incurred | 2017-12-31 | $2,293,330 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2017-12-31 | $2,276,256 |
Value of total corrective distributions | 2017-12-31 | $12,569 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2017-12-31 | $3,116,726 |
Value of total assets at end of year | 2017-12-31 | $40,090,102 |
Value of total assets at beginning of year | 2017-12-31 | $34,462,372 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2017-12-31 | $4,505 |
Total interest from all sources | 2017-12-31 | $27,687 |
Total dividends received (eg from common stock, registered investment company shares) | 2017-12-31 | $822,492 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2017-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2017-12-31 | $822,492 |
Was this plan covered by a fidelity bond | 2017-12-31 | Yes |
Value of fidelity bond cover | 2017-12-31 | $600,000 |
If this is an individual account plan, was there a blackout period | 2017-12-31 | No |
Were there any nonexempt tranactions with any party-in-interest | 2017-12-31 | No |
Contributions received from participants | 2017-12-31 | $1,336,816 |
Participant contributions at end of year | 2017-12-31 | $316,901 |
Participant contributions at beginning of year | 2017-12-31 | $357,701 |
Assets. Other investments not covered elsewhere at end of year | 2017-12-31 | $12,829,393 |
Assets. Other investments not covered elsewhere at beginning of year | 2017-12-31 | $12,298,243 |
Income. Received or receivable in cash from other sources (including rollovers) | 2017-12-31 | $439,338 |
Other income not declared elsewhere | 2017-12-31 | $1,252,574 |
Administrative expenses (other) incurred | 2017-12-31 | $4,505 |
Total non interest bearing cash at end of year | 2017-12-31 | $183 |
Total non interest bearing cash at beginning of year | 2017-12-31 | $52,198 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2017-12-31 | No |
Value of net income/loss | 2017-12-31 | $5,627,730 |
Value of net assets at end of year (total assets less liabilities) | 2017-12-31 | $40,090,102 |
Value of net assets at beginning of year (total assets less liabilities) | 2017-12-31 | $34,462,372 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2017-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2017-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2017-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2017-12-31 | $24,116,185 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2017-12-31 | $18,904,000 |
Interest on participant loans | 2017-12-31 | $15,285 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2017-12-31 | $1,486,868 |
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2017-12-31 | $1,611,281 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2017-12-31 | $1,611,281 |
Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2017-12-31 | $12,402 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2017-12-31 | $2,701,581 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2017-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2017-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2017-12-31 | No |
Contributions received in cash from employer | 2017-12-31 | $1,340,572 |
Employer contributions (assets) at end of year | 2017-12-31 | $1,340,572 |
Employer contributions (assets) at beginning of year | 2017-12-31 | $1,238,949 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2017-12-31 | $2,276,256 |
Did the plan have assets held for investment | 2017-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2017-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2017-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2017-12-31 | Yes |
Opinion of an independent qualified public accountant for this plan | 2017-12-31 | Disclaimer |
Accountancy firm name | 2017-12-31 | BONADIO & CO., LLP |
Accountancy firm EIN | 2017-12-31 | 161131146 |
2016 : HEMATOLOGY-ONCOLOGY ASSOCIATES OF CENTRAL NEW YORK P.C. 401(K) PROFIT SHARING PLAN 2016 401k financial data |
---|
Total unrealized appreciation/depreciation of assets | 2016-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2016-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2016-12-31 | $0 |
Total income from all sources (including contributions) | 2016-12-31 | $4,342,007 |
Total loss/gain on sale of assets | 2016-12-31 | $0 |
Total of all expenses incurred | 2016-12-31 | $3,018,252 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2016-12-31 | $2,999,984 |
Value of total corrective distributions | 2016-12-31 | $13,648 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2016-12-31 | $2,526,462 |
Value of total assets at end of year | 2016-12-31 | $34,462,372 |
Value of total assets at beginning of year | 2016-12-31 | $33,138,617 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2016-12-31 | $4,620 |
Total interest from all sources | 2016-12-31 | $24,791 |
Total dividends received (eg from common stock, registered investment company shares) | 2016-12-31 | $462,558 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2016-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2016-12-31 | $462,558 |
Was this plan covered by a fidelity bond | 2016-12-31 | Yes |
Value of fidelity bond cover | 2016-12-31 | $600,000 |
If this is an individual account plan, was there a blackout period | 2016-12-31 | No |
Were there any nonexempt tranactions with any party-in-interest | 2016-12-31 | No |
Contributions received from participants | 2016-12-31 | $1,223,718 |
Participant contributions at end of year | 2016-12-31 | $357,701 |
Participant contributions at beginning of year | 2016-12-31 | $362,503 |
Assets. Other investments not covered elsewhere at end of year | 2016-12-31 | $12,298,243 |
Assets. Other investments not covered elsewhere at beginning of year | 2016-12-31 | $12,732,573 |
Income. Received or receivable in cash from other sources (including rollovers) | 2016-12-31 | $63,795 |
Other income not declared elsewhere | 2016-12-31 | $340,770 |
Administrative expenses (other) incurred | 2016-12-31 | $4,620 |
Total non interest bearing cash at end of year | 2016-12-31 | $52,198 |
Total non interest bearing cash at beginning of year | 2016-12-31 | $64,613 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2016-12-31 | No |
Value of net income/loss | 2016-12-31 | $1,323,755 |
Value of net assets at end of year (total assets less liabilities) | 2016-12-31 | $34,462,372 |
Value of net assets at beginning of year (total assets less liabilities) | 2016-12-31 | $33,138,617 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2016-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2016-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2016-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2016-12-31 | $18,904,000 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2016-12-31 | $17,030,323 |
Interest on participant loans | 2016-12-31 | $20,786 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2016-12-31 | $1,611,281 |
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2016-12-31 | $1,729,216 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2016-12-31 | $1,729,216 |
Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2016-12-31 | $4,005 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2016-12-31 | $987,426 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2016-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2016-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2016-12-31 | No |
Contributions received in cash from employer | 2016-12-31 | $1,238,949 |
Employer contributions (assets) at end of year | 2016-12-31 | $1,238,949 |
Employer contributions (assets) at beginning of year | 2016-12-31 | $1,219,389 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2016-12-31 | $2,999,984 |
Did the plan have assets held for investment | 2016-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2016-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2016-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2016-12-31 | Yes |
Opinion of an independent qualified public accountant for this plan | 2016-12-31 | Disclaimer |
Accountancy firm name | 2016-12-31 | BONADIO & CO., LLP |
Accountancy firm EIN | 2016-12-31 | 161131146 |
2015 : HEMATOLOGY-ONCOLOGY ASSOCIATES OF CENTRAL NEW YORK P.C. 401(K) PROFIT SHARING PLAN 2015 401k financial data |
---|
Total unrealized appreciation/depreciation of assets | 2015-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2015-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2015-12-31 | $0 |
Total income from all sources (including contributions) | 2015-12-31 | $2,061,220 |
Total loss/gain on sale of assets | 2015-12-31 | $0 |
Total of all expenses incurred | 2015-12-31 | $2,033,264 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2015-12-31 | $2,019,256 |
Value of total corrective distributions | 2015-12-31 | $1,588 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2015-12-31 | $2,479,688 |
Value of total assets at end of year | 2015-12-31 | $33,138,617 |
Value of total assets at beginning of year | 2015-12-31 | $33,110,661 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2015-12-31 | $12,420 |
Total interest from all sources | 2015-12-31 | $14,371 |
Total dividends received (eg from common stock, registered investment company shares) | 2015-12-31 | $808,965 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2015-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2015-12-31 | $808,965 |
Was this plan covered by a fidelity bond | 2015-12-31 | Yes |
Value of fidelity bond cover | 2015-12-31 | $600,000 |
If this is an individual account plan, was there a blackout period | 2015-12-31 | No |
Were there any nonexempt tranactions with any party-in-interest | 2015-12-31 | No |
Contributions received from participants | 2015-12-31 | $1,206,266 |
Participant contributions at end of year | 2015-12-31 | $362,503 |
Participant contributions at beginning of year | 2015-12-31 | $376,579 |
Participant contributions at beginning of year | 2015-12-31 | $30,159 |
Assets. Other investments not covered elsewhere at end of year | 2015-12-31 | $12,732,573 |
Assets. Other investments not covered elsewhere at beginning of year | 2015-12-31 | $11,415,369 |
Income. Received or receivable in cash from other sources (including rollovers) | 2015-12-31 | $54,033 |
Other income not declared elsewhere | 2015-12-31 | $-158,568 |
Administrative expenses (other) incurred | 2015-12-31 | $12,420 |
Total non interest bearing cash at end of year | 2015-12-31 | $64,613 |
Total non interest bearing cash at beginning of year | 2015-12-31 | $3,299 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2015-12-31 | No |
Value of net income/loss | 2015-12-31 | $27,956 |
Value of net assets at end of year (total assets less liabilities) | 2015-12-31 | $33,138,617 |
Value of net assets at beginning of year (total assets less liabilities) | 2015-12-31 | $33,110,661 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2015-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2015-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2015-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2015-12-31 | $17,030,323 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2015-12-31 | $18,038,878 |
Interest on participant loans | 2015-12-31 | $14,175 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2015-12-31 | $1,729,216 |
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2015-12-31 | $1,901,475 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2015-12-31 | $1,901,475 |
Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2015-12-31 | $196 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2015-12-31 | $-1,083,236 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2015-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2015-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2015-12-31 | No |
Contributions received in cash from employer | 2015-12-31 | $1,219,389 |
Employer contributions (assets) at end of year | 2015-12-31 | $1,219,389 |
Employer contributions (assets) at beginning of year | 2015-12-31 | $1,344,902 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2015-12-31 | $2,019,256 |
Did the plan have assets held for investment | 2015-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2015-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2015-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2015-12-31 | Yes |
Opinion of an independent qualified public accountant for this plan | 2015-12-31 | Disclaimer |
Accountancy firm name | 2015-12-31 | BONADIO & CO., LLP |
Accountancy firm EIN | 2015-12-31 | 161131146 |
2014 : HEMATOLOGY-ONCOLOGY ASSOCIATES OF CENTRAL NEW YORK P.C. 401(K) PROFIT SHARING PLAN 2014 401k financial data |
---|
Total unrealized appreciation/depreciation of assets | 2014-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2014-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2014-12-31 | $0 |
Total income from all sources (including contributions) | 2014-12-31 | $4,327,537 |
Total loss/gain on sale of assets | 2014-12-31 | $0 |
Total of all expenses incurred | 2014-12-31 | $1,492,185 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2014-12-31 | $1,473,098 |
Value of total corrective distributions | 2014-12-31 | $5,245 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2014-12-31 | $2,704,393 |
Value of total assets at end of year | 2014-12-31 | $33,110,661 |
Value of total assets at beginning of year | 2014-12-31 | $30,275,309 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2014-12-31 | $13,842 |
Total interest from all sources | 2014-12-31 | $12,887 |
Total dividends received (eg from common stock, registered investment company shares) | 2014-12-31 | $945,516 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2014-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2014-12-31 | $945,516 |
Was this plan covered by a fidelity bond | 2014-12-31 | Yes |
Value of fidelity bond cover | 2014-12-31 | $500,000 |
If this is an individual account plan, was there a blackout period | 2014-12-31 | No |
Were there any nonexempt tranactions with any party-in-interest | 2014-12-31 | No |
Contributions received from participants | 2014-12-31 | $1,236,140 |
Participant contributions at end of year | 2014-12-31 | $376,579 |
Participant contributions at beginning of year | 2014-12-31 | $318,936 |
Participant contributions at end of year | 2014-12-31 | $30,159 |
Assets. Other investments not covered elsewhere at end of year | 2014-12-31 | $11,415,369 |
Assets. Other investments not covered elsewhere at beginning of year | 2014-12-31 | $10,211,796 |
Income. Received or receivable in cash from other sources (including rollovers) | 2014-12-31 | $119,612 |
Other income not declared elsewhere | 2014-12-31 | $399,911 |
Administrative expenses (other) incurred | 2014-12-31 | $13,842 |
Total non interest bearing cash at end of year | 2014-12-31 | $3,299 |
Total non interest bearing cash at beginning of year | 2014-12-31 | $150 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2014-12-31 | No |
Value of net income/loss | 2014-12-31 | $2,835,352 |
Value of net assets at end of year (total assets less liabilities) | 2014-12-31 | $33,110,661 |
Value of net assets at beginning of year (total assets less liabilities) | 2014-12-31 | $30,275,309 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2014-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2014-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2014-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2014-12-31 | $18,038,878 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2014-12-31 | $16,058,656 |
Interest on participant loans | 2014-12-31 | $12,674 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2014-12-31 | $1,901,475 |
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2014-12-31 | $2,409,648 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2014-12-31 | $2,409,648 |
Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2014-12-31 | $213 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2014-12-31 | $264,830 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2014-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2014-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2014-12-31 | No |
Contributions received in cash from employer | 2014-12-31 | $1,348,641 |
Employer contributions (assets) at end of year | 2014-12-31 | $1,344,902 |
Employer contributions (assets) at beginning of year | 2014-12-31 | $1,276,123 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2014-12-31 | $1,473,098 |
Did the plan have assets held for investment | 2014-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2014-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2014-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2014-12-31 | Yes |
Opinion of an independent qualified public accountant for this plan | 2014-12-31 | Disclaimer |
Accountancy firm name | 2014-12-31 | BONADIO & CO., LLP |
Accountancy firm EIN | 2014-12-31 | 161131146 |
2013 : HEMATOLOGY-ONCOLOGY ASSOCIATES OF CENTRAL NEW YORK P.C. 401(K) PROFIT SHARING PLAN 2013 401k financial data |
---|
Total unrealized appreciation/depreciation of assets | 2013-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2013-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2013-12-31 | $0 |
Total income from all sources (including contributions) | 2013-12-31 | $5,726,841 |
Total loss/gain on sale of assets | 2013-12-31 | $0 |
Total of all expenses incurred | 2013-12-31 | $837,524 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2013-12-31 | $827,045 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2013-12-31 | $2,476,627 |
Value of total assets at end of year | 2013-12-31 | $30,275,309 |
Value of total assets at beginning of year | 2013-12-31 | $25,385,992 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2013-12-31 | $10,479 |
Total interest from all sources | 2013-12-31 | $12,864 |
Total dividends received (eg from common stock, registered investment company shares) | 2013-12-31 | $712,859 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2013-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2013-12-31 | $712,859 |
Was this plan covered by a fidelity bond | 2013-12-31 | Yes |
Value of fidelity bond cover | 2013-12-31 | $500,000 |
If this is an individual account plan, was there a blackout period | 2013-12-31 | No |
Were there any nonexempt tranactions with any party-in-interest | 2013-12-31 | No |
Contributions received from participants | 2013-12-31 | $1,180,223 |
Participant contributions at end of year | 2013-12-31 | $318,936 |
Participant contributions at beginning of year | 2013-12-31 | $288,218 |
Assets. Other investments not covered elsewhere at end of year | 2013-12-31 | $10,211,796 |
Assets. Other investments not covered elsewhere at beginning of year | 2013-12-31 | $7,703,200 |
Income. Received or receivable in cash from other sources (including rollovers) | 2013-12-31 | $20,281 |
Other income not declared elsewhere | 2013-12-31 | $500,506 |
Administrative expenses (other) incurred | 2013-12-31 | $10,479 |
Total non interest bearing cash at end of year | 2013-12-31 | $150 |
Total non interest bearing cash at beginning of year | 2013-12-31 | $2,390 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2013-12-31 | No |
Value of net income/loss | 2013-12-31 | $4,889,317 |
Value of net assets at end of year (total assets less liabilities) | 2013-12-31 | $30,275,309 |
Value of net assets at beginning of year (total assets less liabilities) | 2013-12-31 | $25,385,992 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2013-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2013-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2013-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2013-12-31 | $16,058,656 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2013-12-31 | $13,391,940 |
Interest on participant loans | 2013-12-31 | $12,622 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2013-12-31 | $2,409,648 |
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2013-12-31 | $2,794,754 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2013-12-31 | $2,794,754 |
Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2013-12-31 | $242 |
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2013-12-31 | $0 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2013-12-31 | $2,023,985 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2013-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2013-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2013-12-31 | No |
Contributions received in cash from employer | 2013-12-31 | $1,276,123 |
Employer contributions (assets) at end of year | 2013-12-31 | $1,276,123 |
Employer contributions (assets) at beginning of year | 2013-12-31 | $1,205,490 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2013-12-31 | $827,045 |
Did the plan have assets held for investment | 2013-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2013-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2013-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2013-12-31 | Yes |
Opinion of an independent qualified public accountant for this plan | 2013-12-31 | Disclaimer |
Accountancy firm name | 2013-12-31 | TESTONE, MARSHALL AND DISCENZA, LLP |
Accountancy firm EIN | 2013-12-31 | 161076996 |
2012 : HEMATOLOGY-ONCOLOGY ASSOCIATES OF CENTRAL NEW YORK P.C. 401(K) PROFIT SHARING PLAN 2012 401k financial data |
---|
Total unrealized appreciation/depreciation of assets | 2012-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2012-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2012-12-31 | $44,371 |
Total income from all sources (including contributions) | 2012-12-31 | $4,284,203 |
Total loss/gain on sale of assets | 2012-12-31 | $0 |
Total of all expenses incurred | 2012-12-31 | $511,424 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2012-12-31 | $507,271 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2012-12-31 | $2,524,824 |
Value of total assets at end of year | 2012-12-31 | $25,385,992 |
Value of total assets at beginning of year | 2012-12-31 | $21,657,584 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2012-12-31 | $4,153 |
Total interest from all sources | 2012-12-31 | $13,363 |
Total dividends received (eg from common stock, registered investment company shares) | 2012-12-31 | $404,160 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2012-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2012-12-31 | $404,160 |
Was this plan covered by a fidelity bond | 2012-12-31 | Yes |
Value of fidelity bond cover | 2012-12-31 | $500,000 |
If this is an individual account plan, was there a blackout period | 2012-12-31 | No |
Were there any nonexempt tranactions with any party-in-interest | 2012-12-31 | No |
Contributions received from participants | 2012-12-31 | $1,061,539 |
Participant contributions at end of year | 2012-12-31 | $288,218 |
Participant contributions at beginning of year | 2012-12-31 | $312,678 |
Assets. Other investments not covered elsewhere at end of year | 2012-12-31 | $7,703,200 |
Assets. Other investments not covered elsewhere at beginning of year | 2012-12-31 | $7,057,343 |
Income. Received or receivable in cash from other sources (including rollovers) | 2012-12-31 | $257,795 |
Other income not declared elsewhere | 2012-12-31 | $297,683 |
Administrative expenses (other) incurred | 2012-12-31 | $4,153 |
Total non interest bearing cash at end of year | 2012-12-31 | $2,390 |
Total non interest bearing cash at beginning of year | 2012-12-31 | $21,616 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2012-12-31 | No |
Value of net income/loss | 2012-12-31 | $3,772,779 |
Value of net assets at end of year (total assets less liabilities) | 2012-12-31 | $25,385,992 |
Value of net assets at beginning of year (total assets less liabilities) | 2012-12-31 | $21,613,213 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2012-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2012-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2012-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2012-12-31 | $13,391,940 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2012-12-31 | $10,549,159 |
Interest on participant loans | 2012-12-31 | $13,089 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2012-12-31 | $2,794,754 |
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2012-12-31 | $2,691,668 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2012-12-31 | $2,691,668 |
Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2012-12-31 | $274 |
Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2012-12-31 | $0 |
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2012-12-31 | $0 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2012-12-31 | $1,044,173 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2012-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2012-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2012-12-31 | No |
Contributions received in cash from employer | 2012-12-31 | $1,205,490 |
Employer contributions (assets) at end of year | 2012-12-31 | $1,205,490 |
Employer contributions (assets) at beginning of year | 2012-12-31 | $1,025,120 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2012-12-31 | $507,271 |
Liabilities. Value of benefit claims payable at beginning of year | 2012-12-31 | $44,371 |
Did the plan have assets held for investment | 2012-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2012-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2012-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2012-12-31 | Yes |
Opinion of an independent qualified public accountant for this plan | 2012-12-31 | Disclaimer |
Accountancy firm name | 2012-12-31 | TESTONE, MARSHALL AND DISCENZA, LLP |
Accountancy firm EIN | 2012-12-31 | 161076996 |
2011 : HEMATOLOGY-ONCOLOGY ASSOCIATES OF CENTRAL NEW YORK P.C. 401(K) PROFIT SHARING PLAN 2011 401k financial data |
---|
Total unrealized appreciation/depreciation of assets | 2011-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2011-12-31 | $44,371 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2011-12-31 | $0 |
Total income from all sources (including contributions) | 2011-12-31 | $2,290,473 |
Total loss/gain on sale of assets | 2011-12-31 | $641,116 |
Total of all expenses incurred | 2011-12-31 | $647,005 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2011-12-31 | $625,096 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2011-12-31 | $2,401,091 |
Value of total assets at end of year | 2011-12-31 | $21,657,584 |
Value of total assets at beginning of year | 2011-12-31 | $19,969,745 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2011-12-31 | $21,909 |
Total interest from all sources | 2011-12-31 | $16,190 |
Total dividends received (eg from common stock, registered investment company shares) | 2011-12-31 | $365,050 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2011-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2011-12-31 | $365,050 |
Was this plan covered by a fidelity bond | 2011-12-31 | Yes |
Value of fidelity bond cover | 2011-12-31 | $500,000 |
If this is an individual account plan, was there a blackout period | 2011-12-31 | No |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2011-12-31 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2011-12-31 | No |
Contributions received from participants | 2011-12-31 | $1,014,466 |
Participant contributions at end of year | 2011-12-31 | $312,678 |
Participant contributions at beginning of year | 2011-12-31 | $354,932 |
Assets. Other investments not covered elsewhere at end of year | 2011-12-31 | $7,057,343 |
Assets. Other investments not covered elsewhere at beginning of year | 2011-12-31 | $5,770,377 |
Income. Received or receivable in cash from other sources (including rollovers) | 2011-12-31 | $60,879 |
Other income not declared elsewhere | 2011-12-31 | $-90,175 |
Administrative expenses (other) incurred | 2011-12-31 | $21,909 |
Total non interest bearing cash at end of year | 2011-12-31 | $21,616 |
Total non interest bearing cash at beginning of year | 2011-12-31 | $11,144 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2011-12-31 | No |
Value of net income/loss | 2011-12-31 | $1,643,468 |
Value of net assets at end of year (total assets less liabilities) | 2011-12-31 | $21,613,213 |
Value of net assets at beginning of year (total assets less liabilities) | 2011-12-31 | $19,969,745 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2011-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2011-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2011-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2011-12-31 | $10,549,159 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2011-12-31 | $10,781,901 |
Interest on participant loans | 2011-12-31 | $15,939 |
Value of interest in common/collective trusts at beginning of year | 2011-12-31 | $0 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2011-12-31 | $2,691,668 |
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2011-12-31 | $2,268,716 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2011-12-31 | $2,268,716 |
Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2011-12-31 | $251 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2011-12-31 | $-1,042,799 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2011-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2011-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2011-12-31 | No |
Contributions received in cash from employer | 2011-12-31 | $1,325,746 |
Employer contributions (assets) at end of year | 2011-12-31 | $1,025,120 |
Employer contributions (assets) at beginning of year | 2011-12-31 | $782,675 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2011-12-31 | $625,096 |
Liabilities. Value of benefit claims payable at end of year | 2011-12-31 | $44,371 |
Did the plan have assets held for investment | 2011-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2011-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2011-12-31 | No |
Aggregate proceeds on sale of assets | 2011-12-31 | $4,801,931 |
Aggregate carrying amount (costs) on sale of assets | 2011-12-31 | $4,160,815 |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2011-12-31 | Yes |
Opinion of an independent qualified public accountant for this plan | 2011-12-31 | Disclaimer |
Accountancy firm name | 2011-12-31 | TESTONE, MARSHALL AND DISCENZA, LLP |
Accountancy firm EIN | 2011-12-31 | 161076996 |
2010 : HEMATOLOGY-ONCOLOGY ASSOCIATES OF CENTRAL NEW YORK P.C. 401(K) PROFIT SHARING PLAN 2010 401k financial data |
---|
Total unrealized appreciation/depreciation of assets | 2010-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2010-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2010-12-31 | $144,424 |
Total income from all sources (including contributions) | 2010-12-31 | $4,604,741 |
Total loss/gain on sale of assets | 2010-12-31 | $0 |
Total of all expenses incurred | 2010-12-31 | $428,664 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2010-12-31 | $412,072 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2010-12-31 | $2,899,817 |
Value of total assets at end of year | 2010-12-31 | $19,969,745 |
Value of total assets at beginning of year | 2010-12-31 | $15,938,092 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2010-12-31 | $16,592 |
Total interest from all sources | 2010-12-31 | $20,094 |
Total dividends received (eg from common stock, registered investment company shares) | 2010-12-31 | $249,522 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2010-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2010-12-31 | $249,522 |
Was this plan covered by a fidelity bond | 2010-12-31 | Yes |
Value of fidelity bond cover | 2010-12-31 | $600,000 |
If this is an individual account plan, was there a blackout period | 2010-12-31 | Yes |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2010-12-31 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2010-12-31 | No |
Contributions received from participants | 2010-12-31 | $1,017,641 |
Participant contributions at end of year | 2010-12-31 | $354,932 |
Participant contributions at beginning of year | 2010-12-31 | $346,983 |
Assets. Other investments not covered elsewhere at end of year | 2010-12-31 | $5,770,377 |
Income. Received or receivable in cash from other sources (including rollovers) | 2010-12-31 | $1,099,501 |
Other income not declared elsewhere | 2010-12-31 | $404,991 |
Administrative expenses (other) incurred | 2010-12-31 | $16,592 |
Total non interest bearing cash at end of year | 2010-12-31 | $11,144 |
Total non interest bearing cash at beginning of year | 2010-12-31 | $1 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2010-12-31 | No |
Value of net income/loss | 2010-12-31 | $4,176,077 |
Value of net assets at end of year (total assets less liabilities) | 2010-12-31 | $19,969,745 |
Value of net assets at beginning of year (total assets less liabilities) | 2010-12-31 | $15,793,668 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2010-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2010-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2010-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2010-12-31 | $10,781,901 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2010-12-31 | $11,843,617 |
Interest on participant loans | 2010-12-31 | $19,886 |
Value of interest in common/collective trusts at end of year | 2010-12-31 | $0 |
Value of interest in common/collective trusts at beginning of year | 2010-12-31 | $557,545 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2010-12-31 | $2,268,716 |
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2010-12-31 | $2,166,877 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2010-12-31 | $2,166,877 |
Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2010-12-31 | $208 |
Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2010-12-31 | $0 |
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2010-12-31 | $0 |
Expenses. Payments to insurance carriers foe the provision of benefits | 2010-12-31 | $470 |
Asset value of US Government securities at beginning of year | 2010-12-31 | $79,324 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2010-12-31 | $1,030,317 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2010-12-31 | Yes |
Was there a failure to transmit to the plan any participant contributions | 2010-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2010-12-31 | No |
Contributions received in cash from employer | 2010-12-31 | $782,675 |
Employer contributions (assets) at end of year | 2010-12-31 | $782,675 |
Employer contributions (assets) at beginning of year | 2010-12-31 | $943,745 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2010-12-31 | $411,602 |
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2010-12-31 | Yes |
Liabilities. Value of benefit claims payable at beginning of year | 2010-12-31 | $144,424 |
Did the plan have assets held for investment | 2010-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2010-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2010-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2010-12-31 | Yes |
Opinion of an independent qualified public accountant for this plan | 2010-12-31 | Disclaimer |
Accountancy firm name | 2010-12-31 | GRIMALDI & NELKER CPAS PLLC |
Accountancy firm EIN | 2010-12-31 | 300133442 |
2009 : HEMATOLOGY-ONCOLOGY ASSOCIATES OF CENTRAL NEW YORK P.C. 401(K) PROFIT SHARING PLAN 2009 401k financial data |
---|
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2009-12-31 | $0 |